Electronics nose and gas chromatography-mass spectrometry identify CRC through sweat VOCs, indicating high accuracy.
Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, emphasizing the urgent need for early, non-invasive, and accessible diagnostic tools. This study aimed to evaluate the effectiveness of a microelectromechanical systems (MEMS)-based electronic nose (E-nose) in combination with gas chromatography–mass spectrometry (GC-MS) for CRC detection through sweat volatile organic compounds (VOCs). Methods: A total of 136 sweat samples were collected from 68 volunteer participants. Samples were processed using solid-phase microextraction (SPME) and analyzed by GC-MS, while a custom-designed E-nose system comprising 14 gas sensors captured real-time VOC profiles. Data were analyzed using multivariate statistical techniques, including PCA and PLS-DA, and classified with machine learning algorithms (LDA, LR, SVM, k-NN). Results: GC-MS analysis revealed statistically significant differences between CRC patients and healthy controls (COs). Cross-validation showed that the highest classification accuracy for GC-MS data was 81% with the k-NN classifier, whereas E-nose data achieved up to 97% accuracy using the LDA classifier. Conclusions: Sweat volatilome analysis, supported by advanced data processing and complementary use of E-nose technology and GC-MS, demonstrates strong potential as a reliable, non-invasive approach for early CRC detection.
No takes yet. Share an insight, caveat, or question.
Acevedo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: